FH535, a β-catenin pathway inhibitor, represses pancreatic cancer xenograft growth and angiogenesis

The WNT/β-catenin pathway plays an important role in pancreatic cancer carcinogenesis. We evaluated the correlation between aberrant β-catenin pathway activation and the prognosis pancreatic cancer, and the potential of applying the β-catenin pathway inhibitor FH535 to pancreatic cancer treatment. M...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncotarget
Egile Nagusiak: Liu, Lu, Zhi, Qiaoming, Shen, Meng, Gong, Fei-Ran, Zhou, Binhua P., Lian, Lian, Shen, Bairong, Chen, Kai, Duan, Weiming, Wu, Meng-Yao, Tao, Min, Li, Wei
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2016
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5216931/
https://ncbi.nlm.nih.gov/pubmed/27323403
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9975
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak